Your browser doesn't support javascript.
loading
Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.
Ford, Andrew; Hwang, Angela; Mo, Annie X; Baqar, Shahida; Touchette, Nancy; Deal, Carolyn; King, Deborah; Earle, Kristen; Giersing, Birgitte; Dull, Peter; Hall, B Fenton.
Affiliation
  • Ford A; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: aford@niaid.nih.gov.
  • Hwang A; Angela Hwang Consulting, PO Box 6601, Albany, CA 94706, USA. Electronic address: angela@ahwang.net.
  • Mo AX; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: moa@niaid.nih.gov.
  • Baqar S; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: baqars@niaid.nih.gov.
  • Touchette N; Office of Global Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: ntouchette@niaid.nih.gov.
  • Deal C; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: cdeal@niaid.nih.gov.
  • King D; Infectious Disease Health Challenge - Prevention, Wellcome Trust, London NW1 2BE, United Kingdom. Electronic address: D.King@wellcome.ac.uk.
  • Earle K; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA. Electronic address: kristen.earle@gatesfoundation.org.
  • Giersing B; Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland. Electronic address: giersingb@who.int.
  • Dull P; Vaccine Development & Surveillance, Bill & Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA. Electronic address: peter.dull@gatesfoundation.org.
  • Hall BF; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MSC 9825, Bethesda, MD 20892-9825, USA. Electronic address: lhall@niaid.nih.gov.
Vaccine ; 41(11): 1799-1807, 2023 03 10.
Article in En | MEDLINE | ID: mdl-36803897
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Tuberculosis Vaccines / COVID-19 Limits: Humans Language: En Journal: Vaccine Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Tuberculosis Vaccines / COVID-19 Limits: Humans Language: En Journal: Vaccine Year: 2023 Document type: Article